Description: Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Home Page: www.eurofins.com
23 Val Fleuri
Luxembourg City,
1526
Luxembourg
Phone:
352 26 18 53 20
Officers
| Name | Title |
|---|---|
| Dr. Gilles G. Martin Ph.D. | Chairman of the Board & CEO |
| Ms. Valerie Hanote | Executive Director |
| Mr. Laurent Lebras | Group Administration & CFO |
| Mr. Bernard Wang | Head of Investor Relations |
| Ms. Sandra Hoeylaerts | Chief Human Resources Officer |
| Mr. David W. Bryant | Senior VP of Strategic Business Development North America |
| Mr. Gabriel Julia | Senior VP of Clinical Diagnostics Europe |
| Dr. Timothy S. Oostdyk | Executive VP of BioPharma, Genomics & Agrosciences Services North America |
| Mr. Joachim Reichelt | Senior Vice President of Food & Feed Testing Europe |
| Ms. Yvoine Remy | Senior Vice President of Environment Testing Europe |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 12.7877 |
|---|---|
| Trailing PE: | 24.5876 |
| Price-to-Book MRQ: | 1.7052 |
| Price-to-Sales TTM: | 1.3297 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 62000 |